acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/sumypharma/public_html/wp-includes/functions.php on line 6121OHM is a substitutes benzimidazole gastric anti secretory agent and is also known as PPI. It blocks the final step in gastric acid selection by specific inhibition of H+/K+ATPase enzyme, which is present on the surface of the gastric parietal cell.
Usual Adult Dose for Gastric Ulcer
40 mg orally once a day
-Duration of therapy: 4 to 8 weeks
Use: Short-term treatment of active benign gastric ulcer
Usual Adult Dose for Erosive Esophagitis
Treatment: 20 mg orally once a day
-Duration of therapy: 4 to 8 weeks
Maintenance: 20 mg orally once a day
Usual Adult Dose for Duodenal Ulcer
20 mg orally once a day
-Duration of therapy: 4 weeks
Use: Short-term treatment of active duodenal ulcer
Usual Adult Dose for Helicobacter pylori Infection
Dual therapy: 40 mg orally once a day, taken concomitantly with clarithromycin
-Duration of therapy: 14 days
Usual Adult Dose for Zollinger-Ellison Syndrome
Initial dose: 60 mg orally once a day
Maximum dose: 360 mg/day (as 120 mg orally 3 times a day)
Usual Adult Dose for Gastroesophageal Reflux Disease
20 mg orally once a day
-Duration of therapy: Up to 4 weeks
Use: Treatment of heartburn and other symptoms associated with GERD
Usual Adult Dose for Dyspepsia
Over-the-Counter (OTC) formulations: 20 mg orally once a day in the morning
-Duration of therapy: 14 days